As of November 6, 2026, Zoetis Inc. is a publicly traded company (NYSE: ZTS); its largest reported holder is BlackRock, with 9% on Schedule 13G/A of July 30, 2026, then Vanguard (7.17%). The largest insider holding is Kristin C. Peck, the chief executive and a director, with 105,901.64 shares (0.03% of shares outstanding), per Form 4 of February 23, 2026 (Schedule 13G/A, July 30, 2026).
Is this your company?
About to sign with, pay or invest in Zoetis Inc.? See the free Snapshot first.
Free to see. No signup.
Is Zoetis Inc. a real, registered company?
- Zoetis Inc. files with the SEC under CIK 1555280 (its SEC filings).
- Its shares are listed under the ticker ZTS on NYSE (SEC company record).
- business address in Parsippany, New Jersey, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under ZOETIS INC in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Iris Knobloch (Form 8-K filed 2026-10-13). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names BlackRock (filed 2026-07-30).
Who are Zoetis Inc.'s owners and officers?
Zoetis Inc.: business address in Parsippany, New Jersey; industry Pharmaceutical Preparations (Form D, 2026-10-13).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-07-30 | Blackrock, Inc. | 9% |
| Schedule 13G, 2026-04-30 | Vanguard Capital Management | 7.17% |
| Schedule 13G, 2026-04-29 | Vanguard Portfolio Management | 5.7% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G/A, 2026-01-07 | The Vanguard Group | 10.84% |
Questions about who owns Zoetis Inc.
Who owns Zoetis Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Zoetis Inc.: Blackrock, Inc. (9%, Schedule 13G/A, filed 2026-07-30), Vanguard Capital Management (7.17%, Schedule 13G, filed 2026-04-30) and Vanguard Portfolio Management (5.7%, Schedule 13G, filed 2026-04-29).
Who are the largest shareholders of Zoetis Inc.?
By the share each holder's latest filing reports, the largest holders of Zoetis Inc. on this page are Blackrock, Inc. (9%), Vanguard Capital Management (7.17%) and Vanguard Portfolio Management (5.7%).
When did Blackrock, Inc. buy into Zoetis Inc.?
The filings give report dates, not purchase dates. The earliest filing from Blackrock, Inc. on this page is the Schedule 13G/A, filed 2026-07-30, reporting 9%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 5 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Zoetis Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Zoetis Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Zoetis Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-10-13 | Iris Knobloch | appointed | ||
| Form 8-K, 2026-08-06 | James Saccaro | Chief Financial Officer and Chief Operating Officer | appointed | 2026-08-17 |
Which insiders own Zoetis Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive and a director: 105,901.64 shares (0.03% of shares outstanding), 105,068 held directly and 833.64 indirectly (Form 4, 2026-02-23).
- , a director: 31,893 shares (0.01% of shares outstanding), held indirectly through a trust (Form 4, 2026-06-11).
- , a director: 29,079 shares (0.01% of shares outstanding), 21,489 held directly and 7,590 indirectly (Form 4, 2025-05-23).
- , a director: 28,394 shares (0.01% of shares outstanding) (Form 4, 2026-05-21).
- , a director: 27,862 shares (0.01% of shares outstanding) (Form 4, 2026-05-13).
Shares outstanding: 406,316,147 as of 2026-10-30, from the company's latest SEC cover page.
How much has Zoetis Inc. raised?
No fundraising or offering filing from Zoetis Inc. is on file with us.
Keep reading
More on Zoetis Inc. and the records around it.
Zoetis Inc. elsewhere on the record
- Leadership changes Aug 2026
Companies that share a holder
- Vanguard Portfolio Management also filed stake reports on 941 other companies: Newmark Group Inc (Nov 2026), A10 Networks Inc (Oct 2026), ADT Inc (Oct 2026)
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/zoetis